Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bartram

Showing results (291-300 of 317) with videos related to

Pageof 32
Sort By:
Breast Cancer Research and Treatment|September 25, 2007
The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter studyBernd Frank, Sushila H Rigas, Justo Lorenzo Bermejo, et al.
Nature Communications|November 27, 2019
Identification of four novel associations for B-cell acute lymphoblastic leukaemia riskJayaram Vijayakrishnan, Maoxiang Qian, James B Studd, et al.
EMBO Molecular Medicine|January 16, 2010
A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survivalKatharina Rauschenberger, Katja Schöler, Jörn Oliver Sass, et al.
Blood|September 3, 2013
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotypeGabriele Migliorini, Bettina Fiege, Fay J Hosking, et al.
Human Molecular Genetics|September 19, 2013
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemiaBarbara Meissner, Thies Bartram, Cornelia Eckert, et al.
Leukemia|October 4, 2016
A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1J Vijayakrishnan, R Kumar, M Y R Henrion, et al.
International Journal of Cancer|May 14, 2019
Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillanceChristoph Engel, Christine Fischer, Silke Zachariae, et al.
Haematologica|April 5, 2011
Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemiaAmy L Sherborne, Kari Hemminki, Rajiv Kumar, et al.
Nature Genetics|May 11, 2010
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia riskAmy L Sherborne, Fay J Hosking, Rashmi B Prasad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2018
IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic LeukemiaMartin Stanulla, Elif Dagdan, Marketa Zaliova, et al.
Pageof 32

Showing results (291-300 of 317) with videos related to

Sort By:
Pageof 32
Breast Cancer Research and Treatment|September 25, 2007
The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter studyBernd Frank, Sushila H Rigas, Justo Lorenzo Bermejo, et al.
Nature Communications|November 27, 2019
Identification of four novel associations for B-cell acute lymphoblastic leukaemia riskJayaram Vijayakrishnan, Maoxiang Qian, James B Studd, et al.
EMBO Molecular Medicine|January 16, 2010
A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survivalKatharina Rauschenberger, Katja Schöler, Jörn Oliver Sass, et al.
Blood|September 3, 2013
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotypeGabriele Migliorini, Bettina Fiege, Fay J Hosking, et al.
Human Molecular Genetics|September 19, 2013
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemiaBarbara Meissner, Thies Bartram, Cornelia Eckert, et al.
Leukemia|October 4, 2016
A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1J Vijayakrishnan, R Kumar, M Y R Henrion, et al.
International Journal of Cancer|May 14, 2019
Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillanceChristoph Engel, Christine Fischer, Silke Zachariae, et al.
Haematologica|April 5, 2011
Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemiaAmy L Sherborne, Kari Hemminki, Rajiv Kumar, et al.
Nature Genetics|May 11, 2010
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia riskAmy L Sherborne, Fay J Hosking, Rashmi B Prasad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2018
IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic LeukemiaMartin Stanulla, Elif Dagdan, Marketa Zaliova, et al.
Pageof 32